Neuroimaging is a non-invasive and safe technique of measuring brain structure, function, and neurochemistry to understand the neural underpinnings of psychological processing. Structural imaging, measured by magnetic resonance imaging (MRI), provides information about the brain’s anatomical structure, which is utilised in the assessment of brain trauma, neurodegenerative diseases, or age-related atrophy. Functional imaging, measured by functional magnetic resonance imaging (fMRI), provides information about neural activity during the completion of cognitive, perceptual, or motoric tasks. Magnetic resonance spectroscopy (MRS) provides information about the biochemical composition of brain tissue, which can fluctuate in healthy individuals and undergoes profound changes in multiple neurological and psychiatric conditions.
Neuroimaging research is conducted at the Institute of Life Science, Swansea University, on Siemens 3T Magnetom Skyra MRI scanner, which has a wide (70cm) and short (173cm) bore to aid in participant compliance and comfort, without compromising image quality.